Tag Archives: Frank Scholz

NorthStar, Convergent Therapeutics Expand Partnership

NorthStar Medical Radioisotopes has expanded its strategic collaboration with Convergent Therapeutics, the company announced recently. According to a release, NorthStar will: Provide Convergent with Ac-225 for use in CONVO1-a, Use…

NorthStar Sponsors Major Study

NorthStar Medical Radioisotopes has entered into a sponsorship agreement with an undisclosed major U.S. research institution, which will undertake an investigator-initiated research project titled, “Program to Find a Cure for…

NorthStar Signs Agreement With BWXT Medical

NorthStar Medical Radioisotopes and BWXT Medical Ltd., have signed a master services agreement that will facilitate the production of actinium-225 (Ac-225), a medical isotope used to kill cancer cells while…

NorthStar, Monopar Extend Collaboration

NorthStar Medical Radioisotopes has amended and expanded its existing collaboration with Monopar Therapeutics, the company announced recently. According to a release, the long-term, non-exclusive master supply agreement states that NorthStar…

NorthStar, Clarity Pharmaceuticals Establish Agreement

NorthStar Medical Radioisotopes is signing a clinical supply agreement with Clarity Pharmaceuticals for the production of 67Cu-SAR-bisPSMA drug product for Clarity’s Phase I/II and Phase III trials, the company recently…

NorthStar Expands Agreement with Curadh

NorthStar Medical Radioisotopes has expanded its strategic collaboration with Curadh, the organization announced today. According to a release, under the new agreement, NorthStar will manufacture and distribute patient doses for…

NorthStar, Curadh Establish Partnership

NorthStar Medical Radioisotopes has established a partnership with Curadh MTR Inc., a global molecularly targeted radiation (MTR)-focused organization, the company announced recently. According to a release, NorthStar will supply its…

NorthStar Reports First Patient Treated Using its Radioisotope

NorthStar Medical Radioisotopes announced today the first patient to be treated using the radioisotope Copper-67 (Cu-67) produced from its electron accelerator.  According to a release, the administration of the therapeutic…

NorthStar, Bayer Establish Agreement

NorthStar Medical Radioisotopes announced today that it will provide Bayer with its environmentally preferred, non-carrier added (n.c.a.) therapeutic medical radioisotope, actinium‐225 (Ac‐225). “We are very pleased to enter this Ac-225…